Author

Emily Sabbagh Page 4

At a comprehensive cancer center in New Haven, Connecticut, Emily Sabbagh, PharmD, BCOP, serves as an oncology clinical pharmacist. Over the past 10 years, Sabbagh has reviewed chemotherapy regimens, monitored drug interactions, and counseled patients who are beginning targeted therapies or biologics. She received her doctor of pharmacy degree from the University of North Carolina at Chapel Hill and works alongside oncologists to help manage medication side effects throughout treatment.

What Is Anti-VEGF Therapy and How Does It Work?
The Mechanism of Action of Crizotinib
The Cisplatin Structure and Its Role in Cancer Treatment
What Are the Long-Term Side Effects of G-CSF?
How Methotrexate Works: The Cellular Mechanism of Action
Tazemetostat Mechanism of Action: How It Inhibits EZH2
What Is the Half-Life of 5-FU and How Is It Processed?
Why Rasburicase and G6PD Deficiency Don’t Mix
What Are RAF Inhibitors and How Do They Work?
Ifosfamide Neurotoxicity: Causes, Symptoms, and Treatment
Sotorasib’s Mechanism of Action on the KRAS G12C Mutation
Elotuzumab Mechanism of Action: How the Drug Works
Difluoromethylornithine: How It Works & What It’s Used For
Fenbendazole: Mechanism, Metabolism, and Cellular Impact in Humans
Pgp Inhibitors: Their Role, Mechanisms, and Potential
Octreotide Mechanism of Action and Hormone Regulation
MMAE ADC: Chemistry, Mechanism, and Clinical Insights
Trodelvy MOA: A Detailed Look at Its Mechanism of Action
Selumetinib for Adults: Therapeutic Potential and Efficacy
Synergistic Effect of Drugs: Mechanisms and Key Factors
Enzalutamide vs Abiraterone: Mechanisms & Hormone Balance
Treosulfan: Mechanism, Pharmacokinetics, and Clinical Impact
Nivolumab vs Pembrolizumab: Mechanisms, Indications, and Reactions
Why Does Tamoxifen Cause Blood Clots? An In-Depth Look
Tyrosine Kinase Inhibitors Side Effects: Clinical Insights